Reversal With Sugammadex From Deep Neuromuscular Blockade Induced by Rocuronium in Children: Randomised Clinical Trial
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to prove that the administration of sugammadex at a
dose of 4 mg/kg for counteracting deep blockage [without train-of-four (TOF) ratio response
and post-tetanic count (PTC) < of 2 induced and maintained with Rocuronium in pediatric
patients for short-term elective surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Collaborators:
Hospital Universitario Santa Maria del Rosell Hospital Universitario Virgen de la Arrixaca